Figure 1 — Oral maintenance therapy using apatinib combined with S-1/capecitabine for esophageal squamous cell carcinoma with residual disease after definitive chemoradiotherapy

Navigate

Research Paper|Volume 13, Issue 6|pp. 8408–8420

Oral maintenance therapy using apatinib combined with S-1/capecitabine for esophageal squamous cell carcinoma with residual disease after definitive chemoradiotherapy

Back to articleFigure 1(1 of 2)

100%

Figure 1.The PFS (Left) and OS (Right) of the whole cohort.

Figure 1 — Oral maintenance therapy using apatinib combined with S-1/capecitabine for esophageal squamous cell carcinoma with residual disease after definitive chemoradiotherapy | Aging